oral liposomal compounded glp-1 A new chapter in treatment is here. Meet Foundayo™ by Eli Lilly, the first FDA-approved GLP-1, designed to support weight loss through a convenient once-daily approach. Prescription-only treatment, with instant Designing GLP-1 delivery: structural perspectives

Supplementation of a gamma-tocopherol-rich mixture of tocopherols in healthy men protects against vascular endothelial dysfunction induced by postprandial hyperglycemia

10.1186/s12903-019-0734-4 21 IlkunO.BoudinaS

Serum concentrations of n-3 PUFAs have shown an inverse association with both the extent of skin lesions and the PASI scores in patients ( In the fat-1 mouse model, which has the unique ability to endogenously transform n-6 PUFAs into n-3 PUFAs, the prevalence of Th17 cells in the spleen is notably diminished in contrast to wild-type IMQ-treated mice

Emerging research interests include: Neuroprotection and Cognitive Function: Investigating how Klow blend, when stacked with peptides known for neurotrophic or cognitive-enhancing properties (e.g., Selank, Semax derivatives), might impact neuronal health and cognitive performance in research models